Vaccines

What have we learned from the pandemic and how can we address the coming challenges?

In this video roundtable, experts discuss the COVID-19 pandemic and the progress made so far.

The UK approves Pfizer/BioNTech’s COVID-19 vaccine for emergency use.

There is a promising pipeline of vaccine candidates, but what happens if the frontrunners fail?

Sitting Down With… Elaine O’Hara, Chief Commercial Officer at Sanofi Pasteur.

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.